Can continued therapy keep OCD symptoms at bay?

NCT ID NCT03511534

Ongoing Disease control Sponsor: Stanford University Source: ClinicalTrials.gov ↗

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This study offers open/aftercare treatment to adults with obsessive-compulsive disorder (OCD) who have completed an earlier study at Stanford's Rodriguez Lab. Participants receive evidence-based psychotherapy and/or pharmacotherapy from trained professionals. The goal is to see if continued treatment can improve OCD symptoms, measured by a standard scale. The study is open to English-speaking adults who can consent and are not actively suicidal.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Evidenced-based psychotherapy and pharmacotherapy
What this could lead to: If successful, this aftercare approach could help maintain or further reduce OCD symptoms after initial treatment, pointing toward better long-term management strategies.
What could go wrong: This is an open-label, non-randomized study without a control group, so improvements may not be solely due to the treatment. Results may not generalize to all OCD patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OCD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obsessive-compulsive disorder obsessive-compulsive personality disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OCD

Contacts and locations

Locations

Stanford University

Stanford, California, 94305, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.